VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | -10.3% | 5,498 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $165 | -7.3% | 5,498 | 0.0% | 0.02% | -15.8% |
| Q1 2023 | $178 | +13.4% | 5,498 | 0.0% | 0.02% | +46.2% |
| Q4 2022 | $157 | -100.0% | 5,498 | -58.0% | 0.01% | -75.0% |
| Q3 2022 | $315,000 | +108.6% | 13,085 | +138.0% | 0.05% | +160.0% |
| Q2 2022 | $151,000 | -50.5% | 5,498 | -30.8% | 0.02% | -41.2% |
| Q1 2022 | $305,000 | +20.1% | 7,941 | 0.0% | 0.03% | +9.7% |
| Q4 2021 | $254,000 | +8.5% | 7,941 | 0.0% | 0.03% | 0.0% |
| Q3 2021 | $234,000 | -13.3% | 7,941 | 0.0% | 0.03% | -22.5% |
| Q2 2021 | $270,000 | – | 7,941 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |